1. Home
  2. MRVI vs CARE Comparison

MRVI vs CARE Comparison

Compare MRVI & CARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • CARE
  • Stock Information
  • Founded
  • MRVI 2014
  • CARE 1974
  • Country
  • MRVI United States
  • CARE United States
  • Employees
  • MRVI N/A
  • CARE N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • CARE Major Banks
  • Sector
  • MRVI Health Care
  • CARE Finance
  • Exchange
  • MRVI Nasdaq
  • CARE Nasdaq
  • Market Cap
  • MRVI 449.6M
  • CARE 456.8M
  • IPO Year
  • MRVI 2020
  • CARE N/A
  • Fundamental
  • Price
  • MRVI $3.69
  • CARE $17.74
  • Analyst Decision
  • MRVI Buy
  • CARE
  • Analyst Count
  • MRVI 7
  • CARE 0
  • Target Price
  • MRVI $4.54
  • CARE N/A
  • AVG Volume (30 Days)
  • MRVI 1.6M
  • CARE 86.2K
  • Earning Date
  • MRVI 11-06-2025
  • CARE 10-23-2025
  • Dividend Yield
  • MRVI N/A
  • CARE N/A
  • EPS Growth
  • MRVI N/A
  • CARE 118.48
  • EPS
  • MRVI N/A
  • CARE 1.36
  • Revenue
  • MRVI $192,435,000.00
  • CARE $154,517,000.00
  • Revenue This Year
  • MRVI N/A
  • CARE $10.69
  • Revenue Next Year
  • MRVI $7.27
  • CARE $14.79
  • P/E Ratio
  • MRVI N/A
  • CARE $13.10
  • Revenue Growth
  • MRVI N/A
  • CARE 20.24
  • 52 Week Low
  • MRVI $1.67
  • CARE $13.61
  • 52 Week High
  • MRVI $6.21
  • CARE $20.53
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 61.86
  • CARE 55.39
  • Support Level
  • MRVI $3.37
  • CARE $16.86
  • Resistance Level
  • MRVI $3.76
  • CARE $17.55
  • Average True Range (ATR)
  • MRVI 0.25
  • CARE 0.40
  • MACD
  • MRVI 0.05
  • CARE 0.13
  • Stochastic Oscillator
  • MRVI 94.02
  • CARE 60.67

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About CARE Carter Bankshares Inc.

Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.

Share on Social Networks: